Smith Group Asset Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$47.2M Buy
+701,347
New +$46.7M 1.92% 26
2025
Q4
Sell
-33,130
Closed -$2.23M 176
2025
Q3
$2.23M Hold
33,130
0.13% 60
2025
Q2
$2.89M Sell
33,130
-8,870
-21% -$695K 0.19% 50
2025
Q1
$2.87M Hold
42,000
0.22% 52
2024
Q4
$3.27M Buy
+42,000
New +$3.11M 0.24% 52
2024
Q2
Sell
-81,000
Closed -$11.2M 153
2024
Q1
$11.2M Sell
81,000
-33,200
-29% -$4.17M 0.64% 55
2023
Q4
$14.2M Buy
+114,200
New +$11.7M 0.82% 51

Other funds holding DXCM

Smith Group Asset Management's DXCM Position: Q2 2026 in Review

Smith Group Asset Management opened a new position in DexCom (DXCM) in Q2 2026: 701,347 shares worth $47.2M. The stake represents 1.92% of the portfolio and ranks #26 among its holdings. This is a return to the name: Smith Group Asset Management previously reported a position in DXCM as recently as Q3 2025.

Smith Group Asset Management first reported a position in DXCM in Q4 2023 and has held it in 7 quarters since. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Smith Group Asset Management held 701,347 shares of DexCom worth $47.2M as of Q2 2026.
  • DexCom was a new Smith Group Asset Management position in Q2 2026.
  • DexCom made up 1.92% of Smith Group Asset Management's portfolio in Q2 2026, its #26 holding.
  • Smith Group Asset Management first reported a position in DexCom in Q4 2023 and has held it in 7 quarters since.
  • 973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Smith Group Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.